Neogenomics Inc SEC filings NEO
Neogenomics Inc has 1,001 filings in SEC EDGAR's recent list, going back to Feb 28, 2013. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Dec 12, 2019 | — |
| CORRESP | Letter to the SEC | Nov 21, 2019 | — |
| NT 10-Q | Filing | Nov 13, 2019 | Sep 30, 2019 |
| CORRESP | Letter to the SEC | Nov 4, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2019 | — |
| NT 10-Q | Filing | Nov 9, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Jun 28, 2016 | — |
| CORRESP | Letter to the SEC | Jun 27, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2016 | — |
| EFFECT | Filing | May 13, 2016 | — |
| EFFECT | Filing | May 13, 2016 | — |
| EFFECT | Filing | May 7, 2015 | — |
| EFFECT | Filing | May 7, 2015 | — |
| EFFECT | Filing | May 7, 2014 | — |
| EFFECT | Filing | May 7, 2014 | — |
| DEFR14A | Definitive revised proxy statement | Apr 30, 2014 | — |
| EFFECT | Filing | Jan 3, 2014 | — |
| EFFECT | Filing | May 10, 2013 | — |
| EFFECT | Filing | May 10, 2013 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- NEO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fort Myers, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1077183
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC (until Feb 5, 2002)
Other Services-Testing Laboratories companies
- UL Solutions Inc. ULS
- 20/20 Biolabs, Inc. AIDX
- Hypha Labs, Inc. FUNI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.